Review strategies for managing common side effects of tyrosine kinase inhibitors (TKIs) • Explore practical approaches and best practices for optimizing patient care • Discuss techniques for monitoring and improving adherence with oral therapy for patients on TKIs
This ancillary program is presented by Bayer and held in conjunction with the ONS's 41st Annual Congress (PP-550-US-0261)